tert-Butyl 1-methylsulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazole-5-carboxylate, 98%, 100mg

tert-butyl N-[(6-hydroxyquinolin-5-yl)methyl]carbamate, 95.0%, 1g

ETHYL 5-HYDROXYPIPERIDINE-3-CARBOXYLATE, 95.0%, 1g

METHYL 3-METHYLAZETIDINE-3-CARBOXYLATE HCL, 95.0%, 100mg

3-Bromo-4-fluorophenol>99.0%(GC)(T)5g

2,5-Bis(morpholinomethyl)benzene-1,4-diol, 95.0%, 500mg

tert-Butyl (10-aminodecyl)carbamate, 95.0%, 10g

4-(4-Aminophenoxy)-n,n-dimethylpyridine-2-carboxamide, 95%, 250mg

tert-Butyl (R)-(3-(3-(3,4-dimethoxyphenyl)-1-hydroxypropyl)phenyl)carbamate, 98%, 100mg

Octadecylcyclohexane>98.0%(GC)25g

3-Bromo-5-fluorobenzaldehyde, 98.0%, 5g

N,O-Bis(trimethylsilyl)trifluoroacetamide Kit BSTFA 1 mL * 8 / Reaction vial, capacity 2 mL * 81kit

(R)-8-(Benzyloxy)-5-(2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)quinolin-2(1H)-one, 98%, 100mg